Steve Hoerter

2017

In 2017, Steve Hoerter earned a total compensation of $2.3M as Chief Commercial Officer at Agios Pharmaceuticals, a 44% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$205,177
Option Awards$1,639,353
Salary$427,451
Other$9,397
Total$2,281,378

Hoerter received $1.6M in option awards, accounting for 72% of the total pay in 2017.

Hoerter also received $205.2K in non-equity incentive plan, $427.5K in salary and $9.4K in other compensation.

Rankings

In 2017, Steve Hoerter's compensation ranked 4,867th out of 14,666 executives tracked by ExecPay. In other words, Hoerter earned more than 66.8% of executives.

ClassificationRankingPercentile
All
4,867
out of 14,666
67th
Division
Manufacturing
1,736
out of 5,768
70th
Major group
Chemicals And Allied Products
516
out of 2,074
75th
Industry group
Drugs
399
out of 1,730
77th
Industry
Pharmaceutical Preparations
318
out of 1,329
76th
Source: SEC filing on April 18, 2018.

Hoerter's colleagues

We found four more compensation records of executives who worked with Steve Hoerter at Agios Pharmaceuticals in 2017.

2017

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

2017

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2017

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2017

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like